73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Enovis Corp
Closed
SectorIndustrials
26.85 -6.77
Overview
Share price change
24h
Min
26.85
Max
26.85
Income | -534M -571M |
|---|---|
Sales | -16M 549M |
Profit margin | -104.008 |
Employees | 7,367 |
EBITDA | -545M -478M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +56.95% upside |
Market Cap | -249M 1.5B |
|---|---|
Previous open | 33.62 |
Previous close | 26.85 |
Enovis Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Enovis Corp Forecast
Price Target
By TipRanks
56.95% upside
12 Months Forecast
Average 45.25 USD 56.95%
High 50 USD
Low 40 USD
Based on 9 Wall Street analysts offering 12 month price targets forEnovis Corp - Dist in the last 3 months.
Financials
$
About Enovis Corp
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Live chat